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Each of the two highly conserved tryptophan residues in hTNF (positions 28 and 114) was converted into phenylalanine 
by site-directed mutagenesis and the mutant proteins were partially purified. A cytotoxicity assay on mouse L929 cells 
showed only a slight reduction in biological activity, strongly suggesting that neither of the two amino acids is involved 
in the active site. 
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1. INTRODUCTION 
Human and murine tumor necrosis fractors 
(hTNF and mTNF), products derived from 
macrophages, exist as trimers consisting of three 
equal subunits of 17 kDa [1,2]. The monomers 
have a length of 157 and 156 amino acids and show 
a homology of 79%. Both contain an unusually 
long prepeptide of 76 and 79 amino acids respec- 
tively, with an even higher degree of amino acid 
conservation of 86% [3]. The amino acid sequence 
of the rabbit TNF (rTNF) revealed a monomer of 
154 amino acids with 80% homology, as compared 
with hTNF. Lymphotoxin (LT), also referred to as 
hTNF$, a related lymphokine produced by lym- 
phocytes, is preceded by a classical signal peptide 
[4]; the mature human and mouse contain 172 and 
169 amino acids, giving a homology of 28 and 
31070, respectively, with the corresponding TNF 
[5&l. 
Comparing these 5 related sequences, four 
strongly conserved regions can be deduced (posi- 
tions 11-15, 48-64, 119-133, 152-157; hTNF 
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numbering) (fig.1). TNF contains a central region 
which has no similarity to the lymphotoxins and is 
almost completely enclosed between the two con- 
served cysteine residues (positions 69, 101). Cys 69 
can still be found in mLT. These cysteine residues 
in TNF form a disulfide bridge, that is probably 
not necessary for maintaining the overall confor- 
mation as shown by CD spectra [7,8]. Fluorescence 
spectra and quenching, however, indicated that, 
although the biological activity was not reduced 
significantly, the local conformation around the 
two tryptophan residues was affected after remov- 
ing this disulfide bond [9]. 
Our attention was attracted by these two tryp- 
tophan residues which are highly conserved among 
all the molecules sequenced so far. Here, we 
evaluate whether this conservation is related to 
their functional importance, or whether these 
residues play a merely structural role. We con- 
verted each tryptophan residue by site-specific 
mutagenesis into phenylalanine (Phe) and subse- 
quently examined the effect on the cytotoxic activi- 
ty of hTNF for malignant cells. It was found that 
the two mutant proteins, 28F and 114F, only ex- 
hibit a somewhat reduced specific activity: 45 and 
3O(r/, of wild type, respectively. This indicates that 
these residues are not involved in the active site. 
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!4OUSE LT LEU SER CLT VAL - - ARC PHE SEA ALA ALA ARC THR ALA HIS PRO LEU PRO CLN LIS HIS LEO THR AIS GLI ILR LEU 
HIMAN LT LEO PRO CLY VAL CLI LEU THR PRO SER ALA ALA GLN THR ALA ARC CLN HIS PRO LYS KET HIS LEU ALA HIS SER THR LEU 
HUMAN TNF 
MOUSE TNF 
RABBIT TNF 
60 
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Fig. 1. Amino acid sequence comparison of TNFs and LTs. Numbering refers to the mature hTNF sequence. Homology between TNFs, 
or between TNFs and LTs is represented by fine and bold boxes, respectively, Cys residues by dashed boxes and the two strongly 
conserved Trp residues by hatched boxes. The four strongly conserved regions are underlined. Adapted from Tavernier et al. [5]. 
2. MATERIALS AND METHODS using a selection method based on uracil-containing single- 
stranded templates of Ml3 DNA [lo]. Hybridization was per- 
2.1. Insertion of the hTNF gene into Ml3 mpll DNA formed with oligonucleotides containing the proposed muta- 
The entire hTNF gene, coupled to the tryptophan A ter- tions and removing or introducing a restriction site (fig.3, see 
minator sequence (TA), was inserted into the Ml3 mpll vector also section 3). 
which was opened by EcoRI and HindIII. This was done using 
an EcoRI-BstE2 fragment (from the pPLc-mu236-hTNF1 2.3. Subcloning of the mutant genes into an expression vector 
plasmid [3]) and the BstE&indIII fragment from the pPL- and control of expression 
T4-hTNF-T vector (fig.2). The genes containing either the 28F or 114F mutations were 
transferred as AvaI-Hind111 fragments from the Ml3 vector to 
2.2. Site-specific mutagenesis of the recombinant hTNF gene the AvaI-HindIII-opened pMa-T4-hTNF-TA vector (fig.2), 
Mutagenesis of the two tryptophan residues was performed resulting in the phasmids pMa-T4-hTNF28FTA or pMa- 
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Fig.2. Insertion of the wild-type hTNF gene into the Ml3 mpll vector from the plasmids pPLc-mu236-hTNF1 and pPL-Td-hTNF-TA 
followed by insertion of the mutant genes into the pMa-T4-hTNF-TA expression vector. Only relevant restriction sites are shown. The 
hTNF cDNA information is indicated as a filled-in bar. Open arrows represent promoters; the hatched box is the Trp A terminator 
sequence. ApR, ampicillin resistance; TcR, tetracyclin resistance; CmR, chloramphenicol resistance. 
hTNF 
28F PROBE 
(26-mer) 
Trp28 
GAG GGG CAG CTC CAG %? CTG AAC CGC CGG CCC AAT 
G CAG CTG CAG TTC CTG AAC CGC CGG G , 
Pvu2 Phe 
Pstl 
Trpl14 
hTNF GAG CCC AAG CCC ‘TGG ’ TAT GAG CCC ATC TAT CTG CGA GGG 
BstNl 
ScrFl 
114F PROBE CC AAG CCC , TTC , TAT GAG CCC ATC TAT CTG G 
(32-mer) Phe Sau3A 
Fig.3. Oligonucleotide sequences used for mutagenesis and screening of mutants. Differing bases appear in bold on the probe sequence. 
Disappearing and appearing restriction sites are underlined on the wild-type hTNF sequence and the oligonucleotide sequence, 
respectively. The Trp and Phe codons are indicated by horizontal square brackets. 
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mainly insoluble 28F and mainly soluble 114F mu- 
tant proteins, respectively, both constituting about 
30%-of the total protein content (fig.4). - 
T4-hTNF114F-TA, and transformed to E. coli MC1061. The 
pMa phasmid was originally constructed for generating ssDNA 
of an inserted gene; it can however, also be used as an expres- 
sion system [I 11. To test the solubility and expression level, 1 ml 
culture was sonicated and centrifuged. The pellet, containing 
the insoluble fraction, was dissolved in 100 pl Laemmli buffer 3.2. Purification of the mutant proteins 
[12] whereas the supernatant was precipitated with 5 vols Although the 28F mutation resulted in a mainly 
ethanol and spun down. The resulting pellet was also redis- 
solved in 100 ~1 Laemmli buffer. 10 ~1 of each sample was run 
on an SDS-polyacrylamide gel (15%) as described [12]. A. II I] 2 I] 3 )I 4 I] 5 ]I 6 ]I 7 J 
2.4. Purification of the mutated hTNF proteins 
The procedure described by Tavernier et al. [13] was follow- 
ed, with the exception that the mutant proteins were only 
purified over a Mono-Q column (Pharmacia, Sweden), while 
the wild-type protein used as a control was further purified by 
means of an additional Mono-S chromatography step. Elution 
of the 28F and 114F mutants was controlled by a cytotoxicity 
assay [14] and/or by SDS-polyacrylamide gel electrophoresis. 
2.5. Determination of the specific activity - 
An aliquot (2 ~1) of the partially purified product was diluted 
in 800 ~1 Hz0 and 200 pl of the Biorad protein dye reagent was 
added in order to measure the total protein concentration in a 
Beckmann DU-7 spectrophotometer. To calculate the concen- 
trations of mutant proteins, their purity percentage was 
measured by running the mixture on a 15% SDS- 
polyacrylamide gel followed by scanning on a chromatogram 
densitometer CD-50 (Desaga, Heidelberg). 
The cytotoxic activity of the samples was tested on L929 
mouse fibroblast cells [14]. 
3. RESULTS 
3.1. Conversion of the position 28 and 114 
tryptophan residues into phenylalanine by 
site-specific mutagenesis 
Using the selection method based on uracil- 
containing single-stranded templates of Ml 3 DNA 
[lo] for site-specific mutagenesis as described 
above, we generated 8% transitions to the Phe 
residue at position 28 and 50% at position 114, as 
tested by hybridization with the same 32P-labeled 
oligonucleotide sequence as used for mutagenesis. 
These probes also generated a PstI and a PvuI 
restriction site in addition to the 28F mutation (28F 
probe, 26-mer); they also generated a Sau3A site 
and deleted a ScrFI as well as a BstNI site adjacent 
to the 114F mutation (114F probe, 32-mer) (fig.3). 
As a result of this, we could simply monitor the 
presence of the mutations by restriction analysis. 
The mutated genes were then transferred to the 
expression vector pMa and analysis of the resulting 
constructions pMa-T4-hTNF28F-TA and pMa- 
T4-hTNF114F-TA in E. coli MC1061 revealed 
- 97.5 kDa 
- 66 kDa 
- 42.5 kDa 
Ma 
kDa 
kDa 
Ma 
Ma 
kDa 
kDa 
Fig.4. Expression of the 28F and 114F mutant proteins. 
Samples were prepared as described in section 2 and analyzed 
on a 15% SDS-polyacrylamide gel. (A: lysed cultures) Lanes: 
1,5, hTNF 28F; 2,6, hTNF (wild-type); 3,7, hTNF 114F; l-3, 
soluble fractions; lanes 5-7, insoluble fractions of the lysates; 
4, Biorad molecular mass markers. (B: purified proteins) Lanes: 
1, hTNF 28F; 2,4, Biorad molecular mass markers; 3, hTNF 
114F. 
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insoluble TNF protein, the soluble fraction still 
contained sufficient biological activity to warrant 
purification. hTNF-28F eluted at 160 mM NaCl 
from the Mono Q column with a purity of about 
12% relative to the total protein concentration of 
the fraction (fig.4). The eluted samples were tested 
for the presence of hTNF-28F in a cytotoxicity 
assay and checked for purity on an SDS- 
polyacrylamide gel. 
The more soluble 114F mutant protein eluted at 
280 mM NaCl from the Mono-Q column, with a 
purity of about 90% relative to the total protein 
concentration of the fraction, as judged by SDS- 
polyacrylamide gel electrophoresis (fig.4). 
3.3. Cytotoxic activity of the 28F and 114F 
mutant proteins 
The same samples as used for SDS- 
polyacrylamide gel electrophoresis were tested in 
an L929 cytotoxicity assay. This allowed us to 
determine the specific activity to be 8.5 x lo6 and 
5 x lo6 U/fig for the 28F and 114F mutant TNF 
proteins, respectively. As the specific activity of 
the wild-type protein is about 2 x lo7 U/mg [5], 
those of the 28F and the 114F mutant proteins can 
be estimated at 45 and 30%, respectively, of the 
wild-type activity. 
4. DISCUSSION 
We have shown that the replacement of either of 
the two highly conserved tryptophan residues in 
hTNF by phenylalanine does not markedly lower 
the cytotoxic activity of the molecule. Because 
tryptophan and phenylalanine have similar 
chemical characteristics, we hoped to cause 
minimal structural distortion in order to maintain 
the hTNF molecule in the native conformation. As 
observed for the 28F mutation, even a single con- 
servative mutation is, however, sufficient to con- 
vert a soluble protein into a mainly insoluble form. 
Also, the 114F mutation seems to convert the wild- 
type protein, normally eluting from Mono Q at 
140 mM NaCl, into a clearly different structure, 
eluting at 280 mM NaCl. 
If the Trp residues were part of the active site 
responsible for cytotoxicity, one would expect that 
conversion into another amino acid, even with 
similar characteristics, would result in a drastic 
drop in cytolytic activity. Thus, it is likely that 
these two Trp residues play only a structural role, 
and that they perhaps are located sufficiently far 
from the active site that a local structural change 
does not interfere with cytotoxic activity. 
However, because the mutant proteins eluted on a 
gel filtration column (TSK, G 3000 SW, BRL) at 
the same position as the wild-type protein, it is 
unlikely that the Trp residues affect the 
oligomerization and that the slightly reduced ac- 
tivity should be due to a monomeric form. Also, 
these tryptophan residues might play an important 
role during the biosynthesis of TNF in eucaryotic 
cells or could affect post-translational events, such 
as secretion. 
Similar results were obtained by Valenzuela et 
al. [ 151, who examined three amino acids in the 
human interferon-a protein, two of which were 
highly conserved in the different human 
interferon-a species and even the human 
interferon-p protein (intraspecies), and one was 
strictly conserved between man, mouse and 
livestock (interspecies). 
Proteins mutated into these three amino acids 
did, however, maintain their antiviral activity. 
Pielak reported that the phylogenetically con- 
served phenylalanine 87 in yeast iso-1-cytochrome 
c is not directly involved in electron transfer, but 
performs a structural function by controlling the 
polarity of the heme environment [16]. Also, cy- 
globin, mutated at the strongly conserved positions 
127 and 141, seems to be functionally active, and 
persons carrying these mutations are asymp- 
tomatic [17,18]. 
So far, no satisfactory explanation for the con- 
servation of the tryptophan residues in TNF and 
LT has been advanced. More insight into this 
phenomenon may be gained, however, when the 
two amino acids have been located on a three- 
dimensional model of the molecule. Crystals of 
hTNF have already been obtained and X-ray dif- 
fraction studies are in progress [ 191. 
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